P38 Protein A Potential Therapeutic Target for Friedreich’s Ataxia, Study Shows

Inhibitors of p38 — a protein involved in regulating cell growth — show potential for use as therapeutic agents in the treatment of Friedreich’s ataxia (FA), a recent study suggests. The study, “Identification of p38 MAPK as a novel therapeutic target for Friedreich’s ataxia,” was published in the journal…